Frequency Therapeutics, Inc. (FREQ)

NASDAQ: FREQ · IEX Real-Time Price · USD
1.11
-0.16 (-12.60%)
At close: May 20, 2022 4:00 PM
1.15
0.04 (3.60%)
After-hours:May 20, 2022 7:38 PM EDT

Income Statement (Trailing)

Millions USD. Fiscal year is Jan - Dec.
Period Ended2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Revenue
9.4214.0724.0235.2734.3736.9831.7444.7336.2128.9524.240-0-0
Revenue Growth (YoY)
-72.60%-61.96%-24.34%-21.17%-5.08%27.76%30.96%---------
Gross Profit
9.4214.0724.0235.2734.3736.9831.7444.7336.2128.9524.240-0-0
Selling, General & Admin
36.9137.1836.9734.1530.6127.1223.7221.4818.6214.8412.249.48-7.06-4.34
Research & Development
59.660.926054.4945.8537.4231.7826.8522.0118.7815.5113.84-11.88-11.97
Other Operating Expenses
00000001616161600000
Operating Expenses
96.5198.196.9788.6476.4764.5355.564.3356.6349.6243.7523.32-18.94-16.31
Operating Income
-87.09-84.03-72.95-53.38-42.09-27.55-23.76-19.6-20.41-20.68-19.51-23.32--18.94--16.31
Interest Expense / Income
0.260.370.240.15-0.09-0.99-1.9-2.45-2.4-1.78-0.83-0.14-0.11-0.17
Other Expense / Income
0.320.270.250.08-0.03-0.08-0.15-0.18-0.22-0.150.020.0900.1203.76
Pretax Income
-87.67-84.67-73.43-53.6-41.98-26.48-21.71-16.96-17.8-18.75-18.7-23.260-19.170-20.24
Income Tax
0.030.02-0.010-00.040.060.050.04000-0-0
Net Income
-87.7-84.69-73.42-53.6-41.97-26.51-21.77-17.01-17.83-18.75-18.7-23.26--19.17--20.24
Preferred Dividends
0000000.041.051.051.051.010-0-0
Net Income Common
-87.7-84.69-73.42-53.6-41.97-26.51-21.81-18.06-18.89-19.8-19.71-23.26--19.17--20.24
Shares Outstanding (Basic)
3534343434323331319222221
Shares Outstanding (Diluted)
353434343432333131922-2-1
Shares Change
2.04%6.50%4.16%10.21%10.52%272.90%1428.87%1449.42%-465.23%-185.25%----
EPS (Basic)
-2.55-2.47-2.16-1.59-1.26-0.824.373.800.57-2.29-10.63-13.16--12.53--28.79
EPS (Diluted)
-2.55-2.47-2.16-1.59-1.26-0.824.373.800.57-2.29-10.63-13.16--12.53--28.79
Free Cash Flow Per Share
-2.02-2.30-2.33-2.24-2.00-1.61-1.900.750.973.8326.98---11.41--23.44
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%-----
Operating Margin
-924.82%-597.32%-303.73%-151.36%-122.47%-74.49%-74.85%-43.80%-56.38%-71.42%-80.50%-----
Profit Margin
-931.26%-601.98%-305.68%-152.00%-122.12%-71.68%-68.59%-38.02%-49.25%-64.76%-77.15%-----
Free Cash Flow Margin
-746.64%-561.37%-334.23%-217.42%-198.34%-140.22%-197.75%52.28%83.00%114.53%240.77%-----
Effective Tax Rate
-0.03%-0.02%0.02%0.00%0.01%-0.13%-0.28%-0.27%-0.21%0.00%0.00%0.00%-0.00%-0.00%
EBITDA
-82.92-80.46-70.1-50.77-40.11-25.89-22.38-18.35-19.25-19.72-18.73---18.41--19.53
EBITDA Margin
-880.55%-571.96%-291.86%-143.98%-116.69%-70.00%-70.49%-41.02%-53.17%-68.11%-77.29%-----
EBIT
-87.41-84.3-73.2-53.45-42.07-27.47-23.62-19.42-20.19-20.53-19.53-23.41--19.06--20.06
EBIT Margin
-928.25%-599.26%-304.75%-151.58%-122.39%-74.28%-74.40%-43.40%-55.76%-70.92%-80.58%-----
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).